Endocrinologist

  • Placeholder

    GROWTH HORMONE SUPPRESSION BY GLUCOSE

    0 out of 5

    Glucose normally suppresses growth hormone (< 1-2 ng/mL). Individuals with Acromegaly show no decrease or a paradoxical increase in growth hormone level. After successful treatment, a normal response to glucose treatment is observed, although growth hormone may not fall to normal levels.

    • Pre-test Information:

      Overnight fasting is mandatory.Patient should be at rest for 30 minutes prior to basal sample collection.

    • Report Delivery:

      Daily

  • Placeholder

    TBII; THYROTROPIN – BINDING INHIBITORY IMMUNOGLOBULIN

    0 out of 5

    Measurement of TBII is used to diagnose and manage Graves’ disease, Neonatal hypothyroidism, and Postpartum thyroid dysfunction.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    TBG; THYROXINE BINDING GLOBULIN

    0 out of 5

    The measurement of TBG can be used to establish the presence of TBG deficiency or excess suggested by abnormal Total serum T4 and T3 concentrations in the presence of normal free levels of these hormones. Definitive documentation of a TBG derangement may avoid unnecessary diagnostic procedures and therapy in individuals with harmless congenital TBG anomalies, and in their relatives.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    T4 ANTIBODY

    0 out of 5

    Patients with autoimmune thyroid disease including Hashimoto’s thyroiditis and Grave’s disease occasionally develop autoantibodies to T4 and T3. These autoantibodies interfere with the measurement of T4 and T3 immunoassay. Thus abnormal or disparate T4 and T3 concentrations may be due to autoantibodies.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    T3, REVERSE

    0 out of 5

    The assay may be useful in the diagnosis of non thyroidal illness (NTI). Patients with NTI have low T3 concentrations and increased concentrations of rT3. rT3 may be useful in neonates to distinguish euthyroid sick syndrome from central hypothyroidism.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    T3 ANTIBODY

    0 out of 5

    Patients with autoimmune thyroid disease including Hashimoto’s thyroiditis and Grave’s disease occasionally develop autoantibodies to T4 and T3. These autoantibodies interfere with the measurement of T4 and T3 immunoassay. Thus abnormal or disparate T4 and T3 concentrations may be due to autoantibodies.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    SOMATOSTATIN, PLASMA

    0 out of 5

    Somatostatin is a neurohormone produced in the brain, hypothalamus, and gastrointestinal tract. High concentrations are associated with Somatostatinomas occuring in the pancreas. Elevations are also seen in other Gastrointestinal endocrine secreting tumors, Medullary Thyroid carcinoma and Pheochromocytoma.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    PTHrP; PARATHYROID HORMONE RELATED PEPTIDE

    0 out of 5

    Hypercalcemia of malignancy is a common cause of hypercalcemia specially in hospitalized patients. This is typically not due to excess of PTH hormone, but due to the presence of PTHrP. This assay is used as a diagnostic workup of patients with suspected hypercalcemia of malignancy and hypercalcemia of unknown origin. This test should not be used to exclude cancer or screen tumor patients for humoral hypercalcemia of malignancy.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    PREGNENOLONE

    0 out of 5

    This assay is used as an ancillary test for Congenital Adrenal Hyperplasia (CAH) particularly in those cases in which a diagnosis of 21-hydroxylase and 11-hydroxylase deficiency has been ruled out. It is also used to confirm a diagnosis of 3-beta hydroxydehydrogenase deficiency.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    IGF BINDING PROTEIN – 2; IGFBP – 2

    0 out of 5

    Concentration of IGFBP-2 is inversely related with changes in growth hormone secretion. IGFBP-2 may also be used as a marker of Metastatic prostatic carcinoma.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    IGF BINDING PROTEIN–1; IGFBP–1

    0 out of 5

    IGFBP-1 may be used for monitoring insulin responsiveness, as a marker for insulin producing tumors, monitoring acute fluctuations in insulin action and determining if poor glycemic control is due to inadequate insulin treatment or poor control of dietary intake.

    • Pre-test Information:

      Overnight fasting is mandatory

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    17 – HYDROXYPREGNENOLONE

    0 out of 5

    17-Hydroxypregnenolone is useful in the diagnosis of 3-Beta-Hydroxylase enzyme deficiency, a rare cause of Congenital Adrenal Hyperplasia, and 17-Hydroxylase (p450c17) enzyme deficiency

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    GROWTH HORMONE RELEASING HORMONE; GHRH

    0 out of 5

    There is hypersecretion of Growth hormone in about 99% patients of Acromegaly. The remaining cases result from GHRH hypersecretion by peripheral tumors or rarely endocrine tumors.

    • Pre-test Information:

      Patient to avoid all medications that may influence pituitary secretion.

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    GROWTH HORMONE ANTIBODY

    0 out of 5

    This test is useful in assessing patients who fail to respond to GH replacement therapy. Approximately 5% of patients who are GH deficient and are receiving replacement therapy, will develop neutralising antibodies.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    GLUCAGON

    0 out of 5

    This assay is used for the diagnosis and follow-up of Glucagonamas and other glucagon-producing tumors. It also helps in assessing diabetic patients with problematic hyper/hypoglycemic episodes. It is routinely measured in the diagnostic workup of suspected postprandial hypoglycemia.

    • Pre-test Information:

      Overnight fasting is mandatory

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    ESTROGEN, TOTAL, SERUM

    0 out of 5

    Estrogens are secreted by the gonads, adrenal glands and placenta. Total estrogens provide an overall picture of estrogen status for men and women.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    DIHYDROTESTOSTERONE (DHT), FREE

    0 out of 5

    DHT is a potent androgen derived from testosterone via 5-alpha-reductase activity. DHT avidly binds to sex hormone binding globulin (SHBG). Measurement of Free DHT reflects the amount of hormone available to target tissues.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; report after 2–3 weeks.

  • Placeholder

    DEXAMETHASONE

    0 out of 5

    Measurement of dexamethasone is useful in assuring compliance with Dexamethasone treatment and documenting adequate dosing.

    • Pre-test Information:

      Specimen to be drawb between 8–10 A.M

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    DEOXYCORTICOSTERONE

    0 out of 5

    Deoxycorticosterone (DOC) is a precursor of Corticosterone and Aldosterone. High levels are observed in patients with 11-Hydroxylase deficiency. Patients with DOC secreting tumors also exhibit hypertension.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    CORTISONE (COMPOUND E), 24-HOUR URINE

    0 out of 5

    Measurement of both Free Cortisol and Cortisone are useful in diagnosing patients with low-renin hypertension caused by apparent mineralocorticoid excess. This may be due to either an inherited defect in 11HSDB2 enzyme or an acquired inhibitor of the enzyme by such compounds as glycyrrhizic acid, a component of natural licorice.

    • Pre-test Information:

      Collect urine with 10 g boric acid or keep urine refrigerated during collection

    • Report Delivery:

      Sample by 7th of the month; report after 2–3 weeks.

  • Placeholder

    CORTISOL FREE, SERUM

    0 out of 5

    This assay is preferred as a screening test for Cushing syndrome. It also helps in the diagnosis of Pseudo-hyperaldosteronism due to excessive licorice consumption. The test has limited usefulness in the evaluation of Adrenal Insufficiency.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    ARGININE VASOPRESSIN / ANTI DIURETIC HORMONE (ADH), PLASMA

    0 out of 5

    Arginine Vasopressin (Anti Diuretic Hormone) regulates water readsorption in the kidney reducing diuresis and increasing blood volume and pressure. This assay is useful in the diagnosis and characterization of Diabetes insipidus, diagnosis of Psychogenic water intoxication and as an adjunct in the diagnosis of Syndrome of Inappropriate secretion of Antidiuretic Hormone (SIADH) including ectopic Arginine Vasopressin production.

    • Pre-test Information:

      Patient must be fasting for 6 houprior to sampling. No liquids including water allowed.

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    ALPHA SUBUNIT

    0 out of 5

    This assay is useful in the diagnosis and management of various pituitary, placental, pancreatic and hCG-producing tumors. The assay can also be useful for investigations where alpha subunit is increased under various physiological stimuli, e.g., GnRH stimulation and TRH stimulation tests.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    CORTISOL, SALIVA

    0 out of 5

    Salivary cortisol is used to confirm a diagnosis of hypercortisolism in the evaluation of patients with suspected Cushing’s syndrome. The measurement is conducted late at night (11pm – 12 midnight) which is the physiological nadir for cortisol in patients with normal sleep wake cycles. Loss of this normal diurnal variation is one of the characteristics of Cushing’s syndrome. Cortisol in saliva is in equilibrium with Free plasma Cortisol, biological active component. This assay is 92-100% sensitive & 93-100% specific, hence it serves as the first line test for screening of Cushing’s syndrome.

    • Pre-test Information:

      The ideal sampling time is late at night between 11pm to 12 midnight.

    • Report Delivery:

      Sample by Mon 9 am; Report Same day

  • Placeholder

    BETA CROSSLAPS; BETA CTx

    0 out of 5

    Beta-Crosslaps is released into the bloodstream during bone resorption and serves as a specific marker for the degradation of mature type I collagen. It can be used to monitor antiresorptive therapy; treatment response is demonstrated as early as three months in contrast to Bone mineral density which may take two years to produce reliable results.

    • Pre-test Information:

      Overnight fasting is mandatory

    • Report Delivery:

      Sample by Mon 4 pm; Report Same day

  • Placeholder

    17 – HYDROXYPROGESTERONE, NEWBORN SCREEN; CAH SCREEN

    0 out of 5

    17 – OHP is elevated in patients with Congenital Adrenal Hyperplasia.

    • Pre-test Information:

      Give brief clinical history

    • Report Delivery:

      Sample by Tue / Thu / Sat 5 pm; Report 2 days

  • Placeholder

    TSH, NEWBORN SCREEN

    0 out of 5

    This test should be used only in neonates to screen for thyroid disorders.

    • Pre-test Information:

      Clinical details and drug history must accompany sample.

    • Report Delivery:

      Sample by Tue / Thu / Sat 5 pm; Report 2 days

  • Placeholder

    OSTEOCALCIN; BONE Gla PROTEIN (BGP)

    0 out of 5

    Osteocalcin is the most important non-collagen protein in bone matrix. It is a marker of bone osteoblastic activity and is considered indicative of bone turnover rather than bone formation. This assay helps in monitoring and assessing effectiveness of anti-resorptive therapy in patients treated for Osteopenia, Osteoporosis and Paget’s disease. It is also used as an adjunct in the diagnosis of medical conditions associated with increased bone turnover like bone metastasis, Primary hyperparathyroidism & Renal osteodystrophy.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample by Mon 4 pm; Report Same day

  • Placeholder

    IGF BINDING PROTEIN – 3; IGFBP – 3

    0 out of 5

    Low IGFBP-3 levels are observed in Growth hormone (GH) deficiency / resistance. Elevated levels indicate a sustained overproduction of GH or excessive recombinant human Growth hormone (rhGH) injections. This assay is useful for diagnosing growth disorders and adult GH deficiency. It is also used to monitor rhGH treatment. This test can also be used as an adjunct to IGF-1 & GH in the diagnosis and followup of Acromegaly & Gigantism

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon / Thu 4 pm; Report Same day

  • Placeholder

    CORTISOL, MIDNIGHT, SERUM

    0 out of 5

    Total cortisol concentrations are decreased in Addison’s disease and increased in Cushing’s disease and in other conditions of glucocorticoid excess.

    • Pre-test Information:

      Sample to be drawn 11p.m–12 midnight. 4 hours fasting is recommended.

    • Report Delivery:

      Daily

  • Placeholder

    ACTH

    0 out of 5

    This assay is used to determine the cause of Hypocortisolism & Hypercortisolism states. In a patient with hypocortisolism, an elevated ACTH indicates Primary adrenal insufficiency whereas normal levels are consistent with secondary adranal insufficiency from pituitary or hypothalamic causes. In a patient of hypercortisolism (Cushing’s syndrome), a suppressed value is consistent with Cortisol producing Adrenal adenoma/carcinoma, Primary adrenal micronodular hyperplasia & Exogenous corticosteroid use.

    • Pre-test Information:

      Draw blood between 8–10 a.m.

    • Report Delivery:

      Sample Daily by 4 pm; Report Same day

  • Placeholder

    PTH (PARATHYROID HORMONE), INTACT

    0 out of 5

    This assay is useful for diagnosis and differential diagnosis of hypercalcemia. It also helps in the diagnosis of Primary / Secondary / Tertiary Hyperparathyroidism and Hypoparathyroidism. The assay may be useful in monitoring End stage renal failure patients for possible Renal osteodystrophy.

    • Pre-test Information:

      Fasting sample drawn between 8-10 am

    • Report Delivery:

      Daily

  • Placeholder

    BUCCAL SMEAR FOR BARR BODIES (SEX CHROMATIN)

    0 out of 5
    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 6 pm; Report Next day

  • Placeholder

    HYPOGONADISM PANEL, FEMALES

    0 out of 5

    Hypogonadism means a diminished functional activity of the gonads that may result in reduced sex hormone biosynthesis. Low androgen (e.g., testosterone) levels are referred to as hypoandrogenism and low estrogen (e.g., estradiol) as hypoestrogenism, and may occur as symptoms of hypogonadism in both sexes. Other hormones produced by the gonads which may be decreased by hypogonadism include Progesterone, DHEA, Anti-Müllerian hormone, Activin, and Inhibin. Spermatogenesis and ovulation in males and females, respectively, may be impaired by hypogonadism depending on the degree of severity, resulting in partial or complete infertility. Hypogonadism means a diminished functional activity of the gonads that may result in reduced sex hormone biosynthesis. Low androgen (e.g., testosterone) levels are referred to as hypoandrogenism and low estrogen (e.g., estradiol) as hypoestrogenism, and may occur as symptoms of hypogonadism in both sexes. Other hormones produced by the gonads which may be

    • Pre-test Information:

      Prefered sampling time is Day 2 or Day 3 of menstrual cycle in the morning

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    HYPOGONADISM PANEL, MALES

    0 out of 5

    Hypogonadism means a diminished functional activity of the gonads that may result in reduced sex hormone biosynthesis. Low androgen (e.g., testosterone) levels are referred to as hypoandrogenism and low estrogen (e.g., estradiol) as hypoestrogenism, and may occur as symptoms of hypogonadism in both sexes. Other hormones produced by the gonads which may be decreased by hypogonadism include Progesterone, DHEA, Anti-Müllerian hormone, Activin, and Inhibin. Spermatogenesis and ovulation in males and females, respectively, may be impaired by hypogonadism depending on the degree of severity, resulting in partial or complete infertility. Hypogonadism means a diminished functional activity of the gonads that may result in reduced sex hormone biosynthesis. Low androgen (e.g., testosterone) levels are referred to as hypoandrogenism and low estrogen (e.g., estradiol) as hypoestrogenism, and may occur as symptoms of hypogonadism in both sexes. Other hormones produced by the gonads which may be

    • Pre-test Information:

      Morning sample preferred.

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    CORTISONE : CORTISOL RATIO

    0 out of 5

    Children with Hypoadrenalism exhibit a greater decrease in cortisol as compared with cortisone. Usually in these cases cortisone levels are higher than cortisol levels and the cortisone / cortisol ratio exceeds 1.0. Children with adrenal cancer exhibit normal or high values of cortisol, whereas cortisone levels are decreased and the cortisone / cortisol ratio is nearly zero. The ratio becomes normal after excision of adrenal tumors.

    • Pre-test Information:

      Diurnal variation present; take sample between 8-10 am OR 4-6 pm.

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    CORTICOSTERONE

    0 out of 5

    Measurement of Corticosterone is used as an adjunct to 11-deoxycorticosterone and 11-deoxycortisol measurement in the diagnosis of CYP11B1 and CYP11B2 deficiencies, rare glucocorticoid responsive Hyperaldosteronism and isolated loss of function of 18 hydroxylase and 18 methyloxidase activity of CYP11B2. It also helps to evaluate Congenital Adrenal Hyperplasia in newborns where elevation of 17 hydroxyprogesterone is only moderate.

    • Pre-test Information:

      Diurnal variation present; take sample between 8-10 am OR 4-6 pm.

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    CORTISONE, SERUM

    0 out of 5

    Measurement of both Free cortisol and Cortisone are useful in diagnosing patients with low-renin hypertension caused by apparent mineralocorticoid excess. This may be due to either an inherited defect in 11HSDB2 enzyme or an acquired inhibitor of the enzyme by such compounds as glycyrrhizic acid, a component of natural licorice.

    • Pre-test Information:

      Overnight fasting is preferred. Take sample between 8–10 a.m OR 4–6 p.m

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    STEROID PANEL 3, 13 STEROIDS

    0 out of 5

    Biosynthesis of active steroid hormones occurs in gonads, adrenal glands and other tissues. All these are synthesized by the enzymatic modification of cholesterol. Comprehensive assessment of steroidogenic biosynthetic pathway is useful to screen both common & rare forms of Congenital Adrenal Hyperplasia and other syndromes of adrenal hyper / hypofunction. This kind of assessment facilitates evaluation of precursors / product ratios thereby increasing diagnostic discrimination of adrenal enzymatic disorders.

    • Pre-test Information:

      Diurnal variation present; sample will be taken between 8-10 am OR 4-6 pm.

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    STEROID PANEL 2, 8 STEROIDS

    0 out of 5

    Biosynthesis of active steroid hormones occurs in gonads, adrenal glands and other tissues. All these are synthesized by the enzymatic modification of cholesterol. Comprehensive assessment of steroidogenic biosynthetic pathway is useful to screen both common & rare forms of Congenital Adrenal Hyperplasia and other syndromes of adrenal hyper / hypofunction. This kind of assessment facilitates evaluation of precursors / product ratios thereby increasing diagnostic discrimination of adrenal enzymatic disorders.

    • Pre-test Information:

      Diurnal variation present; sample will be taken between 8-10 am OR 4-6 pm.

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    STEROID PANEL 1, 5 STEROIDS

    0 out of 5

    Biosynthesis of active steroid hormones occurs in gonads, adrenal glands and other tissues. All these are synthesized by the enzymatic modification of cholesterol. Comprehensive assessment of steroidogenic biosynthetic pathway is useful to screen both common & rare forms of Congenital Adrenal Hyperplasia and other syndromes of adrenal hyper / hypofunction. This kind of assessment facilitates evaluation of precursors / product ratios thereby increasing diagnostic discrimination of adrenal enzymatic disorders.

    • Pre-test Information:

      Diurnal variation present; sample will be taken between 8-10 am OR 4-6 pm.

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    STEROID PANEL FOR PREMATURE ADRENARCHE

    0 out of 5

    Adrenarche refers to a maturational increase in the secretion of adrenal androgen precursors, mainly Dehydroepiandrosterone (DHEA) and its sulphate (DHEAS). In premature adrenarche (PA), clinical signs of androgen action appear before the age of 8 – 9 years in girls / boys, concurrently with the circulating DHEAS concentrations above the usually low prepubertal level.

    • Pre-test Information:

      Diurnal variation present; sample will be taken between 8-10 am OR 4-6 pm.

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    STEROID PANEL FOR PCOS / CAH DIFFERENTIATION

    0 out of 5

    Nonclassical 21-Hydroxylase deficiency of CAH manifests in childhood or post puberty. Affected patients shows evidence of androgen excess. This test helps to differentiate PCOS from CAH.

    • Pre-test Information:

      Diurnal variation present; sample will be taken between 8-10 am OR 4-6 pm.

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    STEROID PANEL FOR POLYCYSTIC OVARY SYNDROME (PCOS)

    0 out of 5

    This assay detects biochemical hyperandrogenism in patients suspected of having PCOS. It also helps to rule out virilizing tumors.

    • Pre-test Information:

      Diurnal variation present; sample will be taken between 8-10 am OR 4-6 pm.

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    STEROID PANEL FOR CONGENITAL ADRENAL HYPERPLASIA (CAH)

    0 out of 5

    This assay helps to differentiate 4 common enzyme deficiencies of CAH viz., 21-Hydroxylase, 11β-Hydroxylase, 17-Hydroxylase & 3-Hydroxysteroid Dehydrogenase deficiencies.

    • Pre-test Information:

      Diurnal variation present; sample will be taken between 8-10 am OR 4-6 pm.

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    STEROID PANEL, 21- HYDROXYLASE DEFICIENCY/STRESS DIFERENTIATION

    0 out of 5

    Steroid 21- hydroxylase deficiency accounts for more than 90% of the cases of Congenital Adrenal Hyperplasia (CAH). The classical form of CAH presents in childhood with marked raised 17- hydroxypregesterone (17-OHP). Neonates are screened for CAH by testing 17-OHP levels to reduce mortality and other serious sequelae. False positive results can occur due to physiological stress.This test excludes cases of physiological stress from true 21 Hydroxylase deficiency.

    • Pre-test Information:

      Diurnal variation present; sample will be taken between 8-10 am OR 4-6 pm.

    • Report Delivery:

      Sample Daily by 4 pm; Report 2 days

  • Placeholder

    ALDOSTERONE / PLASMA RENIN DIRECT RATIO

    0 out of 5

    This ratio can be used as a screening test in cases of severe hypertension. The ratio allows detection of cases of Primary Aldosteronism in normokalemic patients.

    • Pre-test Information:

      Overnight fasting is preferred. Patient should be ambulatory or upright 2 houprior to the test

    • Report Delivery:

      Sample by Tue/Fri 9 am; Report Same day

  • Placeholder

    NTx (COLLAGEN CROSS-LINKED N- TELOPEPTIDE), URINE

    0 out of 5

    This assay is used as an adjunct in the diagnosis of all medical conditions associated with increased bone turnover. It is used in the differential diagnosis of Osteomalacia versus Osteoporosis. It predicts bone densitometry response to anti-resorptive therapy for Osteoporosis. It also monitors and assesses effectiveness of therapy in patients treated for Osteopenia, Osteoporosis & Paget’s disease.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon 9 am ; Report Same Day

  • Placeholder

    HOMA-IR; INSULIN RESISTANCE INDEX, C-PEPTIDE MODEL

    0 out of 5

    This assay is used to assess response to treatment in diabetic patients taking exogenous insulin.

    • Pre-test Information:

      Overnight fasting is mandatory

    • Report Delivery:

      Sample Daily by 4 pm; Report Same day

  • Placeholder

    HYPERTHYROID / GRAVE’S DISEASE PANEL

    0 out of 5

    Graves’ disease accounts for 60-80% of Thyrotoxicosis. The prevalence varies amongst populations reflecting genetic factors and iodine intake. Graves’ disease occurs in upto 2% of women but is 1/10th as frequent in men occurring between 20-50 years of age. The hyperthyroidism of Graves’ disease is caused by Thyroid receptor antibodies which helps to monitor the disease. These antibodies in pregnant Graves’ disease patients can cross the placental barrier and lead to Neonatal Thyrotoxicosis.

    • Pre-test Information:

      No Special preparation required

    • Report Delivery:

      Sample Daily by 4 pm; Report Same day

  • Placeholder

    VITAMIN D COMPREHENSIVE

    0 out of 5

    The clinical syndrome of Vitamin D deficiency can be a result of deficient production in the skin, lack of dietary intake, accelerated losses, impaired vitamin D activation or resistance to the biologic effects of vitamin D. In addition intestinal malabsorption of dietary fat leads to Vitamin D deficiency which is further exacerbated in the presence of terminal ileal disease. Vitamin D also helps in the homeostatic mechanisms of calcium, phosphorus and alkaline phosphatase.

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Daily0

  • Placeholder

    VITAMIN D SCREEN

    0 out of 5

    The clinical syndrome of Vitamin D deficiency can be a result of deficient production in the skin, lack of dietary intake, accelerated losses, impaired vitamin D activation or resistance to the biologic effects of vitamin D. In addition intestinal malabsorption of dietary fat leads to Vitamin D deficiency which is further exacerbated in the presence of terminal ileal disease. Intestinal calcium absorption is also controlled by vitamin D.

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Daily

  • Placeholder

    OSTEOSCREEN PANEL

    0 out of 5

    Bone is a dynamic tissue that is remodelled constantly throughout life. It provides a reservoir for calcium, phosphorus, and other ions for homeostatic functions. Several genetic and acquired diseases cause tubular phosphate wasting with Rickets and Osteomalacia. Renal phosphate wasting may be accompanied by low levels of Vitamin D & calcium with evidence of impaired cartilage or bone mineralization.

    • Pre-test Information:

      Collect fasting sample between 8–10 a.m. Avoid use of tourniquet and fist clenching during sampling.

    • Report Delivery:

      Daily

  • Placeholder

    GROWTH HORMONE STIMULATION TEST

    0 out of 5

    This test is used to demonstrate Growth Hormone deficiency in cases of growth retardation, short stature and Dwarfism. To diagnose Growth hormone deficiency as a cause of retardation, at least two different stimulants should be used on different days for confirmation. Exercise to be used as an initial stimulant followed by any other provocative agent.

    • Pre-test Information:

      Overnight fasting is mandatory. Patient should be at rest for 30 minutes prior to basal sample collection.

    • Report Delivery:

      Daily

  • Placeholder

    C-PEPTIDE STIMULATION BY GLUCAGON

    0 out of 5

    C-Peptide stimulation by glucagon is useful in assessing patients for pancreatic beta cell function and reserve. Patients with Type I Diabetes mellitus have decreasing reserves of beta cell function.

    • Pre-test Information:

      12 hours overnight fasting mandatory. Injection Glucagon is not supplied by LPL

    • Report Delivery:

      Daily

     0
  • Placeholder

    TSH STIMULATION BY TRH (THYROTROPIN RELEASING HORMONE)

    0 out of 5

    This test is used for suspected Hypothalamic – Pitutary dysfunction.

    • Pre-test Information:

      Overnight fasting mandatory. Injection TRH is not supplied by LPL

    • Report Delivery:

      Daily

  • Placeholder

    GROWTH DISORDER PANEL

    0 out of 5

    Growth hormone (GH) is known to have direct action on long bone growth in children, but majority of its anabolic and metabolic actions are mediated through intermediary factors like IGFBP 3 & IGF-1. GH deficiency is mostly idiopathic in children whereas Pituitary adenoma is the commonest cause in adults. IGF-1 levels are useful in diagnosing patients with active Acromegaly with low basal GH levels & in suspected cases of Acromegaly who show suppression of GH to normal after glucose administration. IGFBP-3 is used in the differential diagnosis of GH deficiency and Non-GH deficient short children. It is also used to assess nutritional status.

    • Pre-test Information:

      Overnight fasting is mandatory. Patient should be at rest for 30 minutes prior to sample collection.

    • Report Delivery:

      Sample by Mon / Thu 4 pm; Report Same day

  • Placeholder

    LH & TESTOSTERONE, TOTAL

    0 out of 5

    This assay is used for evaluating patients with suspected Hypogonadism, predicting ovulation, evaluating Infertility and diagnosing Pituitary disorders. In addition it also helps to evaluate Erectile dysfunction, loss of libido & Gynecomastia.

    • Pre-test Information:

      In females, preferred sampling time is Day 2 / Day 3 of the menstrual cycle. Specify day of menstrual cycle

    • Report Delivery:

      Daily

  • Placeholder

    TESTOSTERONE, FREE & SEX HORMONE BINDING GLOBULIN

    0 out of 5

    Measurement of Free Testosterone may be useful when disturbances in SHBG are suspected as in obesity and estrogen excess.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon / Thu 9 am; Report Same Day

  • Placeholder

    IGF – I & GROWTH HORMONE PANEL

    0 out of 5

    Low IGF-1 levels are observed in Growth hormone (GH) deficiency / resistance. Elevated levels indicate a sustained overproduction of GH or excessive recombinant human Growth hormone (rhGH) injections. This assay is useful for diagnosing growth disorders and adult GH deficiency. It is also used to monitor rhGH treatment. This test is also used for diagnosis and followup of Acromegaly & Gigantism.

    • Pre-test Information:

      Overnight fasting is mandatory

    • Report Delivery:

      Daily

  • Placeholder

    OSTEOPOROSIS PANEL

    0 out of 5

    Osteoporosis is a condition characterized by decreased bone strength leading to increased risk of fractures. It is prevalent in postmenopausal women, but may also occur in men and women with underlying conditions or risk factors associated with bone demineralization. WHO defines Osteoporosis as a bone density that is 2.5 SD below the mean for young healthy adults of the same sex.

    • Pre-test Information:

      Collect fasting sample between 8–10 a.m. Avoid use of tourniquet and fist clenching during sampling.

    • Report Delivery:

      Sample by Mon 4 pm; Report same day0000000000000000000000000000000000000000000

  • Placeholder

    ANDROLOGY PANEL

    0 out of 5

    Hormones produced by the pituitary, hypothalamus, testicles play a key role in sexual development and sperm production. Abnormalities in other hormonal or organ systems may also contribute to infertility. The Andrology panel is useful in the diagnosis of hyper and hypoandrogen states.

    • Pre-test Information:

      Preferred sampling time for female patients is Day 2 / Day 3 of menstrual cycle

    • Report Delivery:

      Sample by Mon through Sat 9 am; Report Same day

  • Placeholder

    17 – HYDROXY- CORTICOSTEROIDS & 17 – KETOSTEROIDS, 24-HOUR URINE

    0 out of 5

    This test is indicated for evaluation of adrenocortical function and to diagnose glucocorticoid related disorders. They are useful in evaluating gonadal and adrenal disorders.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 4 pm; Report 3 days

  • Placeholder

    TESTOSTERONE STIMULATION BY HCG

    0 out of 5

    Post stimulation, testosterone levels rise to twice that of basal levels. A normal response to HCG is seen in patients with unilateral or bilateral undescended testes, while lack of response is compatible with anorchia or Leydig cell agenesis.

    • Pre-test Information:

      Overnight fasting is mandatory. Both containers must be clearly marked with time and date drawn, and submitted with 1 test request form. Injection HCG is not provided by LPL

    • Report Delivery:

      Daily

  • Placeholder

    FSH & LH STIMULATION BY GONADOTROPIN RELEASING HORMONE (GnRH)

    0 out of 5

    This test is indicated in suspected cases of central precocious puberty, pituitary gonadotropin deficiency and to monitor long acting GnRH analogue therapy.

    • Pre-test Information:

      Overnight fasting is mandatory

    • Report Delivery:

      Daily

  • Placeholder

    P1NP (PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE), TOTAL

    0 out of 5

    P1NP is a marker of osteoblastic activity and is increased in conditions like Paget’s disease, Osteoporosis, Primary / Secondary Hyperparathyroidism & Osteomalacia. This test is used to monitor effectiveness of therapy, identify noncompliance amongst patients and predict fracture risk.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon / Thu 4 pm; Report same day

  • Placeholder

    CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT HIGH DOSE

    0 out of 5

    This test is used for differential diagnosis of ACTH secreting pituitary adenoma from an ectopic ACTH source.

    • Pre-test Information:

      Patient to give fasting baseline sample at 8 a.m. Take 4 mg tablet Dexamethasone orally at 11 p.m. same night. Give second sample next morning at 8 a.m . Patient should not be on steroid therapy.

    • Report Delivery:

      Daily

  • Placeholder

    CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT LOW DOSE

    0 out of 5

    It is a screening test to document true hypersecretion of cortisol. Patients with Cushing syndrome of any cause will fail to suppress their cortisol secretion with a low dose of dexamethasone.

    • Pre-test Information:

      Patient to take tablet Dexamethasone orally at 11 p.m. at night and come for test next morning at 8 a.m. Patient should not be on steroid therapy.

    • Report Delivery:

      Daily

  • Placeholder

    HIRSUTISM PANEL

    0 out of 5

    Hirsutism is defined as excessive growth of terminal hair in women and children in a distribution similar to that in post pubertal men. True hirsutism which is androgen responsive has to be distinguished from hypertrichosis. Causes can be ovarian, adrenal, endocrine, iatrogenic, familial & idiopathic.

    • Pre-test Information:

      An early morning specimen is preferred.

    • Report Delivery:

      Sample by Mon / Thu 9 am; Report Same Day

  • Placeholder

    17-HYDROXYPROGESTERONE (17–OHP) STIMULATION BY ACTH

    0 out of 5

    Timed response testing of 17-OHP provides a sensitive measure for Congenital Adrenal Hyperplasia.

    • Pre-test Information:

      Overnight fasting is mandatory. Synthetic ACTH (Synacthen) is not supplied by LPL.

    • Report Delivery:

      Sample Tue / Sat by 9 am; Report Same day

  • Placeholder

    DHEA STIMULATION BY ACTH

    0 out of 5

    DHEA is a weakly androgenic steroid. Monitoring the response to ACTH infusion is useful in patients in whom Congenital Adrenal Hyperplasia is suspected.

    • Pre-test Information:

      Overnight fasting is mandatory. Synthetic ACTH (Synacthen) is not supplied by LPL.

    • Report Delivery:

      Sample by Tue 9 am; Report Same day

  • Placeholder

    CORTISOL STIMULATION BY ACTH

    0 out of 5

    The cortisol response to infusion of synthetic ACTH is useful in diagnosing patients with adrenal insufficiency (Addisons disease).

    • Pre-test Information:

      Overnight fasting is mandatory. Synthetic ACTH (Synacthen) is not supplied by LPL.

    • Report Delivery:

      Daily.0

  • Placeholder

    ANDROSTENEDIONE STIMULATION BY ACTH

    0 out of 5

    This assay is useful in the diagnosis and differential diagnosis of Hyperandrogenism. It is a crucial sex steroid precursor. In conjunction with other androgenic precursors, it is used in the diagnosis / monitoring of Congenital Adrenal Hyperplasia. It is also useful in diagnosis of Premature adrenarche. Androstenedione response to ACTH may be useful in the differential diagnosis of androgen excess in women.

    • Pre-test Information:

      Overnight fasting is mandatory. Synthetic ACTH (Synacthen) is not supplied by LPL.

    • Report Delivery:

      Sample by Mon / Thu 4 pm ; Report Same day

  • Placeholder

    FISH – SRYGENE

    0 out of 5

    SRY (sex reversal Y) probe detects deletion in Yp11.3 that may be related to gonadal dysgenesis or sex reversal.

    • Pre-test Information:

      Clinical history mandatory.

    • Report Delivery:

      Sample Daily by 4 pm; Report 7 Days

  • Placeholder

    C-PEPTIDE, 24-HOUR URINE

    0 out of 5

    C-Peptide is useful in distinguishing Insulinomas from exogenous insulin administration. It’s concentrations are severely decreased or absent in Type I Diabetes mellitus. C-Peptide is also useful in monitoring patients who have received islet cell or pancreatic transplants.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    ALDOSTERONE, 24-HOUR URINE

    0 out of 5

    This assay is useful in the investigation of Primary Aldosteronism (Adrenal Adenoma / Carcinoma and Adrenal Cortical Hyperplasia) and Secondary Aldosteronism (Renovascular disease, salt depletion, potassium loading, cardiac failure with ascitis and pregnancy).

    • Pre-test Information:

      Keep urine refrigerated during collection

    • Report Delivery:

      Sample by Thu 4 pm; Report Next day

  • Placeholder

    17 – KETOSTEROIDS, 24–HOUR URINE

    0 out of 5

    17-ketosteroids (17-KS) are derived from adrenal cortex and testes and are excreted in the urine. These are metabolites of adrenal and gonadal androgenic steroids. In men, 60-70% & in women nearly 100% of these are produced in the adrenal cortex. They are useful in evaluating gonadal and adrenal disorders.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 4 pm; Report 3 days

  • Placeholder

    MACROPROLACTIN

    0 out of 5

    Hyperprolactinemia may be caused by a complex of prolactin bound to immuno- globulin labelled as Macroprolactin. Hyperprolactinemia attributable to macroprolactin is a frequent cause of misdiagnosis and mismanagement as these patients are asymptomatic. Macroprolactin should be considered if prolactin levels are elevated, but signs and symptoms of hyperprolactinemia are absent or pituitary imaging studies are normal.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    TSI; THYROID STIMULATING IMMUNOGLOBULIN

    0 out of 5

    Graves disease is a classic form of hyperthyroid disease, affecting approximately 0.4% of the population in the United States. It is caused by IgG immunoglobulins, collectively known as thyroid stimulating immunoglobulins (TSI). Patients who are candidates for anti-thyroid drug therapy may not respond to this treatment when TSI levels are markedly elevated. The determination of TSI can also assist in predicting hyperthyroidism in neonates due to placental transmission of the immunoglobulins from mothers with hyperthyroidism.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    TSH ANTIBODY

    0 out of 5

    Patients with autoimmune thyroid disease can develop antibodies to TSH which interfere with TSH measurement. This test aids in understanding disparate laboratory and clinical findings.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    TESTOSTERONE FREE, BIOAVAILABLE & TOTAL

    0 out of 5

    Circulating Testosterone consists of testosterone bound to SHBG and the bioavailable (Free & Bound to Albumin). The latter is biologically active. In men approximately 40% of Total testosterone is albumin bound while in women approximately 20% is albumin bound. This assay is useful in assessing testicular function in males and managing hirsutism, virilization in females.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • -7%
    Placeholder

    HYPOTHYROIDISM / HASHIMOTO’S DISEASE PANEL

    0 out of 5

    Autoimmune Hypothyroidism may be associated with Goiter (Hashimoto disease) or in later stages Atrophic Thyroiditis. The autoimmune process gradually reduces thyroid function with a phase of compensation when normal thyroid hormone levels are maintained by a rise in TSH. This is called Subclinical hypothyroidism. The incidence rate of hypothyroidism is 4 per 1000 women and 1 per 1000 men. The mean age at diagnosis is 60 years and the prevalence of overt hypothyroidism increases with age. Presence of TPO antibodies with subclinical hypothyroidism increases the risk by 4% of developing clinical hypothyroidism.

    • Pre-test Information:

      No Special preparation required

    • Report Delivery:

      Daily

    1,400.00 1,300.00
  • -8%
    Placeholder

    ANDROGEN INDEX

    0 out of 5

    The Androgen index is a ratio of Testosterone & SHBG. It is an indicator of Free Testosterone and has been found to be useful in evaluation of hirsutism.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon / Thu 4 pm; Report Same day

    3,000.00 2,750.00
  • -15%
    Placeholder

    T3 & T4, TOTAL

    0 out of 5

    Total Thyroid hormone levels include protein bound levels and are affected by abnormalities in thyroid hormone binding protein like Thyroid Binding Globulin (TBG). TBG is increased due to effect of estrogens like pregnancy, oral contraceptives & Tamoxifen therapy. TBG is decreased due to effect of excessive androgens and Nephrotic syndrome. In addition, genetic disorders, acute illness, various drugs can all affect thyroid hormone binding. Hence assays that measure unbound or free hormone are preferable than total thyroid hormones.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    400.00 340.00
  • -8%
    Placeholder

    TESTOSTERONE PANEL, TOTAL & FREE

    0 out of 5

    Circulating Testosterone consists of testosterone bound to SHBG and the bioavailable (Free & Bound to Albumin). The latter is biologically active. In men approximately 40% of Total testosterone is albumin bound while in women approximately 20% is albumin bound.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon through Sat 9 am; Report Same day

    • Components:

      2

    2,500.00 2,300.00
  • -17%
    Placeholder

    ANTI THYROID ANTIBODIES PANEL

    0 out of 5

    Measurements of Antithyroid thyroglobulin and Antithyroid peroxidase antibodies are used for the diagnosis of Autoimmune thyroid disease. Positive thyroid autoantibody levels in patients with high normal or slightly elevated thyrotropin levels predicts future development of more profound hypothyroidism. Patients with post-partum thyroiditis with persistently elevated thyroid antibody levels have an increased likelihood of permanent hypothyroidism.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    • Components:

      2

    3,000.00 2,500.00
  • -27%
    Placeholder

    T4, FREE & TSH ULTRASENSITIVE

    0 out of 5

    Ultrasensitive TSH (4th generation) assay helps to determine whether TSH is suppressed, normal or elevated. Normal TSH level excludes a primary abnormality of thyroid function. In combination with free T4 assay, thyroid dysfunction can be easily detected so that appropriate therapy can be initiated.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    1,000.00 730.00
  • -8%
    Placeholder

    T4, FREE & T3, FREE; FT4 & FT3

    0 out of 5

    T3 & T4 are highly protein bound hormones which can be affected by numerous factors like illness, medications and genetic factors that influence protein binding. Therefore it is useful to measure the free or unbound hormone levels which correspond to the biologically available hormone pool.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    800.00 740.00
  • -5%
    Placeholder

    FSH & LH

    0 out of 5

    This assay is useful as an adjunct in the evaluation of menstrual irregularities. It also evaluates patients with suspected hypogonadism, predicts ovulation, evaluates infertility and helps in diagnosing pituitary disorders. Primary hypogonadism results in elevated levels of basal LH & FSH. LH is decreased in Primary ovarian hyperfunction in females & Primary hypergonadism in males.

    • Test Type:

      Blood

    • Pre-test Information:

      In females, preferred sampling time is Day 2 / Day 3 of the menstrual cycle. Specify day of menstrual cycle

    • Report Delivery:

      Daily

    • Components:

      2

    1,000.00 950.00
  • -3%
    Placeholder

    THYROID, COMPREHENSIVE PANEL

    0 out of 5

    Autoimmune thyroid disease is detected by measuring circulating antibodies against TPO & Tg. About 5-15 % of euthyroid women and 2% of euthyroid men have thyroid antibodies. These individuals are at increased risk of developing thyroid dysfunction. This assay quantitates the thyroid antibody levels as well as measures free thyroid hormone levels to assess complete thyroid function.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    • Components:

      5

    3,300.00 3,200.00
  • -9%
    Placeholder

    CORTISOL, MORNING & EVENING, SERUM

    0 out of 5

    Total cortisol concentrations are decreased in Addison’s disease and increased in Cushing’s disease and in other conditions of glucocorticoid excess.

    • Pre-test Information:

      For morning specimen between 7-9 a.m, overnight fasting is preferred. For evening specimen between 3-5 p.m, 4 hfasting is recommended.

    • Report Delivery:

      Daily

    1,100.00 1,000.00
  • -7%
    Placeholder

    THYROID PROFILE, FREE

    0 out of 5

    Assays detecting unbound or free form of thyroid hormones are highly sensitive to detect thyroid dysfunction. They reflect the active form of the hormone, unaffected by non-thyroidal factors. Use of TSH alone as a screening test may be misleading, hence simultaneous measurement of free T3 & T4 are important. TSH should not be used as an isolated laboratory test to assess thyroid function specially in patients with suspected or known pituitary disease.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    • Components:

      3

    1,000.00 930.00
  • -4%
    Placeholder

    Sugar Advanced Package

    0 out of 5
    • Test Type:

      Blood & Urine

    • Pre-test Information:

      Minimum 12 hours fasting is mandatory

    • Report Delivery:

      Daily

    2,800.00 2,699.00
  • -10%
    Placeholder

    Sugar Risk Package

    0 out of 5
    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is mandatory

    • Report Delivery:

      Daily

    1,110.00 999.00
  • Sale
    Placeholder

    Sugar Basic Package

    0 out of 5
    • Test Type:

      Blood & Urine

    • Pre-test Information:

      Minimum 12 hours fasting is mandatory

    • Report Delivery:

      Daily

    1,300.00 1,299.00
  • -6%
    Placeholder

    TSH RECEPTOR ANTIBODY

    0 out of 5

    This assay is used as an aid in the differential diagnosis and monitoring of Grave’s disease. Measurement of TSH receptor antibody in the last trimester of pregnancy in a patient with history of thyroid disease helps in assessing the risk of thyroid disease in neonates.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 4 pm; Report Same day

     

    4,000.00 3,750.00
  • -7%
    Placeholder

    ANTI THYROGLOBULIN ANTIBODY; ANTI Tg

    0 out of 5

    Anti Tg autoantibody measurements are recommended if Anti TPO autoantibody is negative, but clinical suspicion of Autoimmune thyroid disease is high. Detection of these antibodies in cases of Neonatal hypothyrodism suggests transplacental antibody transfer particularly if there is a maternal history of autoimmune thyroiditis.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily0

    1,400.00 1,300.00
  • -7%
    Placeholder

    ANTI THYROID PEROXIDASE ANTIBODY; ANTI TPO

    0 out of 5

    Determination of TPO antibody levels is the most sensitive test for detecting autoimmune thyroid disease like Hashimoto thyroiditis (90%), Idiopathic myxedema and Graves disease (60-80%). Presence of TPO antibodies in subclinical hypothyroidism is associated with an increased risk of developing overt hypothyroidism. This assay helps in the diagnosis of thyroid autoimmune disorders and serves as a diagnostic tool in deciding therapy for subclinical hypothyroidism.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Dail

    1,400.00 1,300.00
  • -5%
    Placeholder

    C-PEPTIDE, POST PRANDIAL, SERUM0

    0 out of 5

    C-Peptide is useful in distinguishing Insulinomas from exogenous insulin administration. It’s concentrations are severely decreased or absent in Type I Diabetes mellitus. C-Peptide is also useful in monitoring patients who have received islet cell or pancreatic transplants.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily0

    1,100.00 1,050.00
  • -4%
    Placeholder

    VITAMIN D 25 – HYDROXY

    0 out of 5
    • 25-Hydroxy vitamin D represents the main body reservoir and transport form. Mild to moderate deficiency is associated with Osteoporosis / Secondary Hyperparathyroidism while severe deficiency causes Rickets in children and Osteomalacia in adults. Prevalence of Vitamin D deficiency is approximately >50% specially in the elderly. This assay is useful for diagnosis of vitamin D deficiency and Hypervitaminosis D. It is also used for differential diagnosis of causes of Rickets & Osteomalacia and for monitoring Vitamin D replacement therapy.

      • Test Type:

        Blood

      • Pre-test Information:

        No special preparation required

      • Report Delivery:

        Daily

    1,300.00 1,250.00
  • -9%
    Placeholder

    VITAMIN D 1, 25-DIHYDROXY

    0 out of 5

    1,25-Dihydroxy vitamin D plays a primary role in the maintenance of calcium homeostasis. A part of circulating 25-hydroxy vitamin D is converted to 1,25-dihydroxy form in the kidneys. Patients who present with hypercalcemia, hyperphosphatemia and low PTH may suffer from unregulated conversion of vitamin D from mono-hydroxy to dihydroxy form as is seen in granulomatous diseases like Sarcoidosis and nutritionally induced Hypervitaminosis D.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Tue / Thu / Sat 9 am; Report Same day

    3,500.00 3,200.00
  • Sale
    Placeholder

    IGF – I; SOMATOMEDIN – C

    0 out of 5

    Low IGF-1 levels are observed in Growth hormone (GH) deficiency / resistance. Elevated levels indicate a sustained overproduction of GH or excessive recombinant human Growth hormone (rhGH) injections. This assay is useful for diagnosing growth disorders and adult GH deficiency. It is also used to monitor rhGH treatment. This test is also used for diagnosis and followup of Acromegaly & Gigantism.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    4,000.00 3,990.00
  • -10%
    Placeholder

    5α- DIHYDROTESTOSTERONE; 5α- DHT

    0 out of 5

    This assay is useful for monitoring patients receiving 5 alpha reductase inhibitor therapy or chemotherapy. It also helps to evaluate patients with possible 5 Alpha reducatse deficiency. Low levels are seen in patients on 5 Alpha reductase inhibitor therapy and in cases of genetic 5 Alpha reductase deficiency.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

    3,000.00 2,700.00
  • -18%
    Placeholder

    DHEA; DEHYDROEPIANDROSTERONE

    0 out of 5

    This assay is useful for the diagnosis and differential diagnosis of Hyperandrogenism specially when used in conjunction with measurement of other sex steroids. It is an adjunct in the diagnosis of Congenital adrenal hyperplasia. It is also useful in the diagnosis of Premature adrenarche.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample by Tue/ Fri 9 am; Report Same day

    3,000.00 2,450.00
  • -20%
    Placeholder

    GLUCOSE, FASTING (F)

    0 out of 5

    Glucose determinations are useful in the detection and management of Diabetes mellitus.

    • Test Type:

      Blood

    • Pre-test Information:

      Minimum 8 hours fasting is mandatory

    • Report Delivery:

      Daily

    100.00 80.00
  • -8%
    Placeholder

    TSH (THYROID STIMULATING HORMONE), ULTRASENSITIVE

    0 out of 5

    This assay is used in the differential diagnosis of Hypothyroidism, as an aid in the diagnosis of Primary Hyperthyroidism, prediction of TRH stimulated TSH response and monitoring patients on thyroid replacement therapy.

    • Test Type:

      Blood

    • Pre-test Information:

      Sample to be given at the same time in followup cases

    • Report Delivery:

      Daily

    400.00 370.00
  • -10%
    Placeholder

    T4, FREE; FT4

    0 out of 5

    Free T4 is the metabolically active fraction of thyroxine. FT4 along with TSH gives an accurate picture of thyroid status in patients with abnormal thyroid binding globulin (TBG) like in pregnancy and individuals on treatment with estrogens, androgens, phenytoin or salicylates. This assay is useful for diagnosing both Hypo / Hyperthyroidism.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    400.00 360.00
  • -10%
    Placeholder

    T3, FREE; FT3

    0 out of 5

    Free T3 is a supplemental test to TSH and free T4 for confirmation of thyroid status. This assay also helps to monitor thyroid hormone replacement therapy. Elevated levels are associated with Thyrotoxicosis or excess thyroid hormone replacement.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    400.00 360.00
  • -12%
    Placeholder

    FSH; FOLLICLE STIMULATING HORMONE

    0 out of 5

    This assay is useful as an adjunct in the evaluation of menstrual irregularities. It also evaluates patients with suspected hypogonadism, predicts ovulation, evaluates infertility and helps in diagnosing pituitary disorders.

    • Test Type:

      Blood

    • Pre-test Information:

      In females, preferred sampling time is Day 2 / Day 3 of the menstrual cycle. Specify day of menstrual cycle

    • Report Delivery:

      Daily

    600.00 530.00
  • -6%
    Placeholder

    SEX HORMONE BINDING GLOBULIN; SHBG

    0 out of 5

    This assay is useful for diagnosis and followup of women with signs and symptoms of androgen excess like Polycystic ovarian syndrome and Idiopathic hirsutism. It is an adjunct in monitoring sex steroid and anti-androgen therapy, diagnosis of disorders of puberty / Thyrotoxicosis and diagnosis & followup of Anorexia nervosa.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon / Thu 4 pm; Report same day

    2,500.00 2,350.00
  • -9%
    Placeholder

    ANDROSTENEDIONE

    0 out of 5

    This assay is useful in the diagnosis and differential diagnosis of Hyperandrogenism. It is a crucial sex steroid precursor. In conjunction with other androgenic precursors, it is used in the diagnosis / monitoring of Congenital Adrenal Hyperplasia. It is also useful in diagnosis of Premature adrenarche.

    • Test Type:

      Blood

    • Pre-test Information:

      An early morning specimen is preferred. In females preferred sampling time is 1 week before or after the menstrual period

    • Report Delivery:

      Sample by Mon / Thu 4 pm; Report Same day

    2,000.00 1,820.00
  • -5%
    Placeholder

    C-PEPTIDE, FASTING, SERUM

    0 out of 5

    C-Peptide is useful in distinguishing Insulinomas from exogenous insulin administration. It’s concentrations are severely decreased or absent in Type I Diabetes mellitus. C-Peptide is also useful in monitoring patients who have received islet cell or pancreatic transplants.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is mandatory.

    • Report Delivery:

      Daily

    1,100.00 1,050.00
  • -13%
    Placeholder

    17 – HYDROXYPROGESTERONE (17-OHP)

    0 out of 5

    17 OHP along with Cortisol and Androstenedione constitutes the best screening test for Congenital adrenal hyperplasia caused by either 11 or 21 hydroxylase deficiency. It is also useful to evaluate females with hirsutism and infertility.

    • Test Type:

      Blood

    • Pre-test Information:

      An early morning specimen is preferred.

    • Report Delivery:

      Sample Tue / Thurs/ Sat by 9 am; Report Same day

    1,500.00 1,300.00
  • -20%
    Placeholder

    TSH (THYROID STIMULATING HORMONE)

    0 out of 5

    TSH is an early indicator of decreased thyroid reserve. This assay helps to diagnose hypothyroidism and hyperthyroidism, monitors T4 replacement or T4 suppressive therapy and quantifies TSH levels in the subnormal range.

    • Pre-test Information:

      Sample to be given at the same time in followup cases

    • Report Delivery:

      Daily

    250.00 200.00
  • -5%
    Placeholder

    T4, TOTAL

    0 out of 5

    Total T4 levels offer a good index of thyroid function when TBG is normal and non-thyroidal illness is not present. This assay is useful for monitoring treatment with synthetic hormones (synthetic T3 will cause low total T4).It also helps to monitor treatment of Hyperthyroidism with Thiouracil or other anti-thyroid drugs.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    200.00 190.00
  • -5%
    Placeholder

    T3, TOTAL

    0 out of 5

    This assay is a useful test for Hyperthyroidism in patients with low TSH and normal T4 levels. It is also used for the diagnosis of T3 toxicosis. It is not a reliable marker for Hypothyroidism. This test is not recommended for general screening of the population without a clinical suspicion of hyperthyroidism.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    200.00 190.00
  • -6%
    Placeholder

    ALDOSTERONE, SERUM

    0 out of 5

    This assay is useful in the investigation of Primary Aldosteronism (Adrenal Adenoma / Carcinoma and Adrenal Cortical Hyperplasia) and Secondary Aldosteronism (Renovascular disease, salt depletion, potassium loading, cardiac failure with ascitis and pregnancy).

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred. Patient should be ambulatory or upright 2 hours prior to the test.

    • Report Delivery:

      Sample by Tue/Fri 9 am; Report Same day

    1,700.00 1,600.00
  • -9%
    Placeholder

    DHEA SULPHATE; DEHYDROEPIANDROSTERONE SULPHATE

    0 out of 5

    This assay is useful in identification of androgen secreting adrenal tumors specially Adrenal carcinomas. It is an adjunct in the diagnosis of Congenital adrenal hyperplasia. It is also useful in the diagnosis of Premature adrenarche.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Daily

    1,100.00 1,000.00
  • -6%
    Placeholder

    GROWTH HORMONE; GH

    0 out of 5

    This assay is useful for the diagnosis of Acromegaly / Gigantism and assessment of treatment efficacy.It is used to diagnose Growth hormone deficiency specially in children with short stature. This test should be used in conjunction with stimulation and suppression tests for definite results.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is mandatory. Patient should be at rest for 30 minutes prior to sample collection.

    • Report Delivery:

      Daily

    800.00 750.00
  • -2%
    Placeholder

    ESTRADIOL (E2), SERUM

    0 out of 5

    This assay is useful for evaluating hypogonadism and oligomenorrhea in females. It assesses ovarian status including follicle development for in vitro fertilization. It evaluates feminization including Gynecomastia in males. This assay forms a part of the diagnosis and work up of precocious and delayed puberty in females. It is also useful in monitoring low dose female hormone replacement therapy in post menopausal women and for monitoring anti-estrogen therapy.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    600.00 590.00
  • -8%
    Placeholder

    CORTISOL, SERUM (EVENING SAMPLE)

    0 out of 5

    Total cortisol concentrations are decreased in Addison’s disease and increased in Cushing’s disease and in other conditions of glucocorticoid excess.

    • Pre-test Information:

      Four hours fasting is recommended. Sample must be drawn between 3-5 p.m

    • Report Delivery:

      Daily

    600.00 550.00
  • -8%
    Placeholder

    CORTISOL, SERUM (MORNING SAMPLE)

    0 out of 5

    Total cortisol concentrations are decreased in Addison’s disease and increased in Cushing’s disease and in other conditions of glucocorticoid excess.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred. Sample must be drawn between 7-9 a.m

    • Report Delivery:

      Daily

    600.00 550.00
  • -14%
    Placeholder

    TESTOSTERONE, TOTAL

    0 out of 5

    This assay is useful for evaluation of men with signs and symptoms of possible Hypogonadism like loss of libido, erectile dysfunction, gynecomastia & infertility. It is also useful in evaluation of boys with delayed or precocious puberty. The assay can be used to monitor anti- androgen therapy as in prostate cancer, precocious puberty & male to female transgender disorders. It helps to evaluate infants with ambiguous genitalia or virilization. The assay can serve as an adjunct in the diagnosis of androgen secreting tumors.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    700.00 600.00
  • -3%
    Placeholder

    TESTOSTERONE, FREE

    0 out of 5

    Circulating Testosterone consists of testosterone bound to SHBG and the bioavailable (Free & Bound to Albumin). The latter is biologically active. In men approximately 40% of Total testosterone is albumin bound while in women approximately 20% is albumin bound.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon through Sat 9 am; Report Same day

    1,900.00 1,850.00
  • -3%
    Placeholder

    VITAMIN D, ULTRASENSITIVE

    0 out of 5

    LC-MS/MS is the gold standard technique for accurate quantification of vitamin D2 & D3. It also measures 3 epi 25 hydroxy vitamin D3 to increase accuracy of the test.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 5 pm; Report Same day

    • Components:

      2

    1,900.00 1,850.00
  • -20%
    Diagnostic Centre in Pune

    GLUCOSE, RANDOM (R)

    0 out of 5

    In a patient with classic symptoms of hyperglycemia or hyperglycemic crises, a random plasma glucose >200 mg/dL confirms Diabetes mellitus.

    • Test Type:  Blood
    • Pre-test Information:  No special preparation required.
    • Report Delivery:  Daily
    100.00 80.00
  • -20%
    Diagnostic Centre in Pune

    GLUCOSE, POST PRANDIAL (PP), 2 HOURS

    0 out of 5

    Glucose determinations are useful in the detection and management of Diabetes mellitus.

    • Test Type:  Blood
    • Pre-test Information:  Collect sample exactly 2 hours after starting a meal
    • Report Delivery:  Daily
    100.00 80.00
  • -8%
    Diagnostic Centre in Pune

    HOMA-IR ; INSULIN RESISTANCE INDEX

    0 out of 5

    This assay is used to assess the risk of developing diabetes and response to treatment with oral hypoglycemic agents.

    • Pre-test Information:  Overnight fasting is mandatory
    •  Report Delivery:  Sample Daily by 4 pm; Report Same day
    1,000.00 920.00
  • -1%
    Diagnostic Centre in Pune

    CHROMOGRANIN A; CGA

    0 out of 5

    Chromogranin A is the first line test for diagnosing Carcinoid tumours. It is used as a follow-up test for treated cases of Carcinoid tumours. It is useful as an adjunct in the diagnosis of other Neuroendocrine tumours including Pheochromocytoma, Pituitary adenomas and functioning & non-functioning Islet cell and Gastrointestinal APUD tumours.

    • Pre-test Information:  No special preparation required
    • Report Delivery:  Sample by Tue / Fri 9 am; Report Same day
    7,000.00 6,900.00